TAYLOR N HAINES

Allopathic & Osteopathic Physicians|Family Medicine MOORESVILLE, NC NPI 1467089474

General Payments — all program years on this page

$539.89

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $432.54 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $432.5422

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $12.251
2023 $95.103
2024 $432.5422

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086956871 Novartis Pharmaceuticals Corporation $21.26 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096593370 Novo Nordisk Inc $24.24 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096698236 Novo Nordisk Inc $18.14 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096850581 Novo Nordisk Inc $25.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096890738 Novo Nordisk Inc $13.16 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097721393 Novo Nordisk Inc $21.49 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104217259 AstraZeneca Pharmaceuticals LP $17.66 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104226791 AstraZeneca Pharmaceuticals LP $14.55 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105215973 AstraZeneca Pharmaceuticals LP $16.73 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115694101 Amgen Inc. $19.13 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115694111 Amgen Inc. $27.27 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116295287 GlaxoSmithKline, LLC. $21.37 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135455591 Lilly USA, LLC $14.19 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135459922 Lilly USA, LLC $14.91 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135459924 Lilly USA, LLC $15.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139352899 Astellas Pharma US Inc $23.99 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139373813 Astellas Pharma US Inc $23.36 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139422531 Astellas Pharma US Inc $19.14 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148324281 Axsome Therapeutics, Inc. $20.32 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153339995 Dexcom, Inc. $21.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153483556 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.60 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154685511 MAYNE PHARMA COMMERCIAL LLC $24.25 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.